Octavio Rettig, a Mexican man active in the early 21st century, has become a controversial figure due to his use and promotion of psychoactive substances derived from the Sonoran desert toad, an amphibian native to the Mexico-Arizona border region. The toad’s venom contains 5-MeO-DMT, a potent hallucinogen known colloquially as the “God molecule” for its intense psychoactive effects.

The psychoactive properties of this toad's venom first gained attention in the early 1980s when users discovered that the substance, secreted from the toad’s poison glands, could be dried and smoked, producing powerful hallucinogenic experiences. Rettig began using dried toad venom as a means to overcome his crack cocaine addiction and later became a shamanic practitioner administering the substance to others.

According to accounts, Rettig claimed 5-MeO-DMT offered therapeutic effects resembling years of conventional therapy in a matter of minutes. However, his approach to treatment raised serious ethical and safety concerns. Reports indicate he administered large doses with minimal medical screening, engaged in sexual relations with some female patients, and allegedly denied responsibility when patients suffered adverse effects or died.

While there is ongoing scientific interest in 5-MeO-DMT for its potential mental health benefits, experts caution that such treatments require rigorous clinical oversight. Rettig’s unregulated methods highlight the risks posed by self-styled wellness practitioners operating outside established medical frameworks.

Observers note that Rettig’s story reflects broader cultural and economic trends, including the rise of charismatic figures who attain authority without traditional qualifications, the commercialization of natural substances, and the blending of spirituality with capitalist enterprise. His case underscores the challenges in regulating alternative therapies and protecting vulnerable individuals from exploitation within the expanding wellness industry.

The use of natural psychoactive compounds like 5-MeO-DMT continues to provoke debate among scientists, regulators, and cultural commentators about their potential therapeutic value versus the hazards of unmonitored use. Amid growing interest in psychedelic treatment, Rettig’s experience serves as a cautionary tale about the dangers of charisma and pseudoscience supplanting professional medical standards.